3 ms·
Before I could formulate a reasonable answer to that question of whether this is "unreasonable" (leaving aside the complicated matter of what that exactly means
by jerf 14y ago
Before I could formulate a reasonable answer to that question of whether this is "unreasonable" (leaving aside the complicated matter of what that exactly means), I'd be interested in a serious analysis of what the costs are; $50,000 may not be so obscene if their costs were $45,000/possible patient, for example. What's the floor here?
If the costs are $10,000s of dollars/patient even before the drug company needs to take profit (and have money to invest in their next drug, after all), then a full investigation of the "blame" for this very expensive very cheap drug must also be pointed at the processes that cost that much in the first place. If it's so bad that MS patients are paying $50,000/year, then perhaps the real problem (or at least a nontrivial part of it) is that the costs of certification have greatly exceeded the benefits.
(But people don't like to think in terms of costs/benefits when it comes to medicine and appear to be willing to incur enormous costs if it allows them to continue pretending they don't have to think about it....)
- bmelton 14y agoAnd to be fair, the last number I saw on clinical trials estimated the cost at between 100 million and 800 million dollars per drug candidate, which means that the sunk cost of any drug that works is going to be pretty high right out of the gate. On top of that, you have a VC-like model where the successes must also pay for the cost of failures as well as the funding of new R&D so that they can keep making new drugs.